Surgalign Holdings, Inc. Common Stock
SRGA
SRGA was delisted on the 30th of June, 2023.
88 hedge funds and large institutions have $132M invested in Surgalign Holdings, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 19 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
12% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 25
4% more capital invested
Capital invested by funds: $127M → $132M (+$5.12M)
9% less funds holding
Funds holding: 97 → 88 (-9)
42% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$820K |
| 2 |
CLG
Cooperman Leon G
|
+$804K |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$698K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$252K |
| 5 |
Morgan Stanley
New York
|
+$251K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Rutabaga Capital Management
Boston,
Massachusetts
|
-$1.66M |
| 2 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
-$1.24M |
| 3 |
KAM
Krensavage Asset Management
New York
|
-$611K |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$525K |
| 5 |
MSL
Mackay Shields LLC
New York
|
-$379K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Ameriprise
Minneapolis,
Minnesota
| – | -$30K | -358 | Closed |
|
102
Lazard Asset Management
New York
| – | -$9K | -112 | Closed |
|
103
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$6K | -71 | Closed |
|
|
QT
104
Quantamental Technologies
White Plains,
New York
| – | -$5K | -60 | Closed |
|
|
TRCT
105
Tower Research Capital (TRC)
New York
| – | -$3K | -43 | Closed |
|
|
HWM
106
Howard Wealth Management
Madison,
Connecticut
| – | +$561 | +8 | New |
|
SRGA Hedge Fund Activity: Q4 2019 in Review
88 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q4 2019, worth a combined $132M — up 4% from $127M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of SRGA and 11 opened new positions — a net loss of 8 holders — while 25 trimmed existing stakes and 28 added.
The largest buyer was Vanguard Group, adding an estimated $820K. The largest seller was Rutabaga Capital Management, exiting entirely with an estimated $1.66M sold.
- 88 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q4 2019, down from 97 in Q3 2019.
- Funds reported $132M of Surgalign Holdings, Inc. Common Stock stock for Q4 2019, up 4% quarter-over-quarter.
- 11 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q4 2019 and 19 closed out, a net change of -8 holders.
- The largest Surgalign Holdings, Inc. Common Stock buyer in Q4 2019 was Vanguard Group, an estimated $820K added.
- The largest Surgalign Holdings, Inc. Common Stock seller in Q4 2019 was Rutabaga Capital Management, an estimated $1.66M sold.
Based on aggregated 13F filings for Q4 2019.